We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Non-Invasive Stool Test to Diagnose Endometriosis and Help Reduce Disease Progression

By LabMedica International staff writers
Posted on 14 Oct 2024
Print article
Image: New research promises a potential non-invasive stool test and novel therapy for endometriosis (Photo courtesy of Shutterstock)
Image: New research promises a potential non-invasive stool test and novel therapy for endometriosis (Photo courtesy of Shutterstock)

Endometriosis, a painful condition impacting nearly 200 million women globally, occurs when tissue similar to the lining of the uterus grows outside its usual location, such as on the intestines or the abdominal lining. This abnormal growth typically leads to bleeding, pain, inflammation, and infertility. On average, it takes about seven years to diagnose endometriosis, and it is often misdiagnosed as a bowel condition. The delays in diagnosis, coupled with the reliance on invasive diagnostic methods and ineffective treatments, highlight the urgent need for better management of this condition. Now, researchers have made promising discoveries that could pave the way for a non-invasive stool test and a new treatment option for endometriosis.

Earlier research conducted on mice by scientists at Baylor College of Medicine (Houston, TX, USA) and their collaborators indicated that the microbiome—communities of bacteria within the body—and their metabolites may play a role in the progression of endometriosis. In the current study, researchers focused on the microbiome's involvement by comparing the bacteria and metabolites in the stools of women with endometriosis to those of healthy women. They found notable differences between the two groups. Specifically, they identified a combination of bacterial metabolites unique to women with endometriosis, including 4-hydroxyindole, a compound produced by beneficial bacteria. Women with endometriosis had lower levels of this metabolite compared to those without the condition. Additionally, extensive research revealed that administering 4-hydroxyindole to animal models of endometriosis effectively prevented the onset and progression of inflammation and pain associated with the disease.

The findings, published in the journal Med, suggest that the stool metabolites found in women with endometriosis could form the basis for a non-invasive diagnostic test, as well as a potential therapeutic approach to slow disease progression. Interestingly, the metabolite profile discovered in endometriosis patients mirrors that seen in inflammatory bowel disease (IBD), hinting at a possible link between the two conditions. This research supports the idea that the microbiome plays a role in both endometriosis and IBD. The team continues to work on developing a non-invasive stool test for diagnosing endometriosis and is conducting further studies to assess the safety and effectiveness of 4-hydroxyindole as a potential treatment for the condition.

“These findings are very exciting,” said Dr. Chandni Talwar from Baylor. “There are studies in animal models of the disease that have shown specific bacterial metabolite signatures associated with endometriosis. Our study is the first to discover a unique metabolite profile linked to human endometriosis, which brings us closer to better understanding the human condition and potentially identifying better ways to manage it.”

Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Progesterone Serum Assay
Progesterone ELISA Kit
New
Silver Member
Static Concentrator
BJP 10

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Immunology

view channel
Image: An immune response is initiated when an antigen-presenting cell (pink) presents foreign material to a T-cell (blue) (Photo courtesy of JAX)

Advanced Imaging Method Maps Immune Cell Connections to Predict Cancer Patients Survival

A growing tumor is influenced not only by the tumor cells themselves but also by the surrounding tissue, which alters its biology. Immune cells communicate by transferring vital signaling proteins to their... Read more

Pathology

view channel
Image: LMU’s Professor Frederick Klauschen developed the novel approach that can improve diagnostic accuracy (Photo courtesy of LMU Munich)

AI Tool Uses Imaging Data to Detect Less Frequent GI Diseases

Artificial intelligence (AI) is already being utilized in various medical fields, demonstrating significant potential in aiding doctors in diagnosing diseases through imaging data. However, training AI... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.